SCD management is costly

The management of sickle cell disease (SCD) is costly and requires extensive healthcare resource utilisation

  • People with SCD may experience frequent hospitalisations,1–3 with 51% of patients requiring at least one hospitalisation per year2
  • For these people, hospital length of stay often exceeds a week (median 7 days) and 41% of patients are readmitted in the following month3
  • In addition of acute hospitalisations, managing the chronic manifestations of SCD is a cause of considerable healthcare expenditure4–7